Cetuximab

0:06:47

Cancer: Cetuximab (Erbitux)

0:06:19

Clinical Development of Cetuximab in Metastatic Colorectal Cancer

0:04:00

Incorporating Cetuximab in Head and Neck Cancer Treatment

0:01:08

Dr. Weinberg on the Role of Cetuximab in Metastatic CRC

0:04:16

FIRE-3 Study: Cetuximab Versus Bevacizumab in Metastatic Colorectal Cancer

0:08:19

Cetuximab use for HNSCC

0:01:24

FIRE-4.5: FOLFOXIRI plus either bevacizumab or cetuximab as 1L treatment of BRAF V600E-mutant mCRC

0:01:50

Dr. Benson on Sequencing Strategies with Cetuximab in CRC

0:10:26

Cetuximab or Chemotherapy in HNSCC?

0:05:27

EPOC Studies: Preoperative Cetuximab in KRAS Wild-Type Colorectal Cancer

0:04:56

Upfront Bevacizumab and Cetuximab Compared in Metastatic Colorectal Cancer

0:01:15

Dr. James Melotek on Cetuximab/Chemotherapy Combinations in Head and Neck Cancer

0:05:35

Skin Care Tips while on EGFRi such as cetuximab and panitumumab

0:01:06

Evaluating the Role of Cetuximab in Metastatic Colorectal Cancer

0:03:48

KRYSTAL-1: Adagrasib as monotherapy or combined with cetuximab in patients with CRC harboring a ...

0:01:35

CRICKET and CAVE: Cetuximab for the treatment of mCRC

0:03:28

Head and neck cancer challenges & cetuximab trial updates

0:02:54

EXTREME regimen vs. cetuximab + cisplatin + paclitaxel for recurrent/metastatic head and neck cancer

0:02:23

SWOG S2107: encorafenib, cetuximab ± nivolumab in previously treated, MSS, BRAFV600E CRC

0:02:11

FIRE-4: evaluation of 1L efficacy of FOLFIRI/cetuximab in patients with RAS-WT mCRC

0:03:01

DEEPER: m-FOLFOXIRI and cetuximab versus bevacizumab in mCRC

0:02:15

Adjusting Dosing to Increase Efficacy of Cetuximab in Head and Neck Cancer

0:10:45

#Cetuximab | Uses, Dosage, Side Effects and Mechanism | Erbitux

0:00:56

Dr. Bekaii-Saab on Tolerability of Encorafenib, Binimetinib, and Cetuximab in BRAF+ CRC